About: American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article by Jack Hirsh et al published April 2003 in Circulation

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у квітні 2003 (uk) im April 2003 veröffentlichter wissenschaftlicher Artikel (de) article scientifique publié en 2003 (fr) article by Jack Hirsh et al published April 2003 in Circulation (en)
publication date	wds:Q56986988-81408060-F65A-4545-B7D7-04A2308C29D7
publication date	2003-04-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q56986988-53E517B5-EC18-4F18-8F0B-8A49D0722D00
language of work or name	English
author name string	wds:Q56986988-37733241-B8E6-4918-B532-F6C9DD62C476 wds:Q56986988-62468F8C-25C9-4A3F-9378-1E58192D8C1E
author name string	Jack Ansell Jack Hirsh
rdfs:label	American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy (en) American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy (nl)
skos:prefLabel	American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy (en) American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy (nl)
name	American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy (en) American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy (nl)
author	wds:Q56986988-4869129C-D688-493C-BCC4-551F82287EEA wds:Q56986988-682CBF69-5F37-4C7C-A4E5-063915196E27
author	Jonathan L. Halperin Valentín Fuster Carulla
title	wds:Q56986988-6499A770-E1F2-40FE-AB8C-12925210385B
title	American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy (en)
page(s)	wds:Q56986988-5A7ED5AD-F3AC-45D3-BAE1-DEB8215554F5
page(s)	1692-1711
instance of	wds:Q56986988-597C3BF5-1B36-4491-A765-1CB14F7EC8E1 wds:Q56986988-6ba8b60f-f0fc-49bf-96c5-4e61f88c63d5
instance of	review article scholarly article
main subject	wds:Q56986988-3101A411-4672-4BC2-97FB-3FA1C27DC6F2
main subject	(RS)-warfarin
PubMed ID	wds:Q56986988-F9645B08-6F7E-4B6D-AB51-75302DFFBCB8
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12668507
PubMed ID	12668507
published in	wds:Q56986988-B71C72A8-9BF5-463E-ABA6-6C14316F6179
published in	Circulation
issue	wds:Q56986988-DC48C7D6-2546-4ABD-8CC6-46375D54CD82
volume	wds:Q56986988-95636F6B-3B4C-4C40-9ACB-36462C8C89AC
issue	12
volume	107
DOI	wds:Q56986988-6C94A757-9321-4FEA-86AC-FDEAB4E5C98D
DOI	http://dx.doi.org/10.1161/01.CIR.0000063575.17904.4E
DOI	10.1161/01.CIR.0000063575.17904.4E
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q56986988
is cites work of	Usefulness of international normalized ratio to predict bleeding complications in patients with end-stage liver disease who undergo cardiac catheterization How well does the target INR level maintain in warfarin-treated patients with non-valvular atrial fibrillation? Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial The application of fuzzy logic to the prescription of antithrombotic agents in the elderly Sulfated, low molecular weight lignins inhibit a select group of heparin-binding serine proteases. Warfarin initiation nomograms for venous thromboembolism Warfarin initiation nomograms for venous thromboembolism Warfarin initiation nomograms for venous thromboembolism CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study. Interaction of warfarin with drugs, natural substances, and foods Treating Thrombosis in the 21st Century Genetic-based dosing in orthopedic patients beginning warfarin therapy. Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin A prospective, randomized pilot trial of model-based warfarin dose initiation using CYP2C9 genotype and clinical data Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues Heart failure in acute ischemic stroke Coagulation assessment with the new generation of oral anticoagulants Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population The future of warfarin pharmacogenetics in under-represented minority groups Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation Oral anticoagulant-associated intracerebral hemorrhage The pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor, are unaffected by a single dose of alcohol Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939--an oral, direct Factor Xa inhibitor--after multiple dosing in healthy male subjects Transitioning from argatroban to warfarin therapy in patients with heparin-induced thrombocytopenia Therapeutic dosing of acenocoumarol: proposal of a population specific pharmacogenetic dosing algorithm and its validation in north Indians An acenocoumarol dosing algorithm using clinical and pharmacogenetic data in Spanish patients with thromboembolic disease Outpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality management Point-of-Care International Normalized Ratio (INR) Monitoring Devices for Patients on Long-term Oral Anticoagulation Therapy: An Evidence-Based Analysis. The critical path of warfarin dosing: finding an optimal dosing strategy using pharmacogenetics Genetic testing before anticoagulation? A systematic review of pharmacogenetic dosing of warfarin Patient time requirements for anticoagulation therapy with warfarin Generic forms of low-molecular-weight heparins: some practical considerations Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL). Management of anticoagulation before and after gastrointestinal endoscopy Dosing of 3-factor prothrombin complex concentrate for international normalized ratio reversal. A randomized controlled trial of dabigatran versus warfarin for periablation anticoagulation in patients undergoing ablation of atrial fibrillation. Effect of distance to health facility on the maintenance of INR therapeutic ranges in rheumatic heart disease patients from Cape Town: no evidence for an association Leflunomide and warfarin interaction: case report and review of the literature Anticoagulant treatment in German family practices - screening results from a cluster randomized controlled trial Factor XIa as a possible new target of antithrombotic therapy The dental patient on oral anticoagulant medication: a literature review Azithromycin and warfarin interaction Completion of therapeutic and safety monitoring tests in Lebanese outpatients on chronic medications: a cross-sectional study The impact of pharmacist-managed oral anticoagulation therapy in older veterans Improving the outcomes of anticoagulation: an evaluation of home follow-up of warfarin initiation New approaches to anticoagulation in atrial fibrillation Identification of the site of binding of sulfated, low molecular weight lignins on thrombin Preconception care for improving perinatal outcomes: the time to act The future of preconception care: a clinical perspective Who receives anticoagulant treatment with warfarin and why? A population-based study in Finland Anticoagulation control of pharmacist-managed collaborative care versus usual care in Thailand Age- and weight-adjusted warfarin initiation nomogram for ischaemic stroke patients. Polysulfated trehalose as a novel anticoagulant agent with dual mode of action

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software